Unable to find any further information...
Parkinson’s breakthrough: Researchers fin... - Cure Parkinson's
Parkinson’s breakthrough: Researchers find way to halt disease progression
Unfortunately, the key words in the article are "in mice."
I wonder if mice use humans for testing their drugs...
ça commence toujours ainsi et c'est très prometteur
Cela peut être encourageant, mais comme pour de nombreux autres essais sur souris réussis, je ne pense pas que je vivrai assez longtemps pour en bénéficier. J'espère que je me trompe.
mon épouse a 38 ans, a été diagnostiquée il y a 5 ans. J'éspère qu'elle bénéficiera des nouvelles technologies rapidement...
Être diagnostiqué à 33 ans a dû être difficile. J'espère et je crois qu'une percée majeure viendra bientôt.
here:
nature.com/articles/s41598-...
"For efficient knock down, we designed and synthesized an amido-bridged nucleic acids (AmNA)-modified antisense oligonucleotide (ASO) that targeted SNCA with improved stability and cellular uptake in vivo. AmNA-ASO efficiently downregulated SNCA at both the mRNA and protein level in vitro and in vivo. Notably, AmNA-ASO was efficiently delivered into the mouse brain by intracerebroventricular injection without the aid of additional chemicals. Furthermore, administration of AmNA-ASO ameliorated neurological defects in PD model mice expressing human wild type SNCA. Taken together, these findings suggest that AmNA-ASO is a promising therapeutic strategy for SNCA-associated pathology in PD."
Possibly helpful but it is a long way from an animal model that tries to replicate Parkinson's to approval for human use.
Bydureon, a repurposed Type 2 Diabetes drug is now in third-stage trials in UK for stopping Parkinson's in its tracks -- results expected 2023. Testing -- mice, open label, double blind -- has been going on for 10 years and it has been positive every time.
Ten years. Geez what on earth could take that long.
Crew
The study:
Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease | 2020 pmc. Scientific Reports.